Pathogenesis and therapy of psoriasis.

Nature 2007 Feb;445(7130):866-73

Laboratory for Investigative Dermatology, The Rockefeller University, 1230 York Avenue, Box 178, New York, New York 10021, USA.

Psoriasis is one of the most common human skin diseases and is considered to have key genetic underpinnings. It is characterized by excessive growth and aberrant differentiation of keratinocytes, but is fully reversible with appropriate therapy. The trigger of the keratinocyte response is thought to be activation of the cellular immune system, with T cells, dendritic cells and various immune-related cytokines and chemokines implicated in pathogenesis. The newest therapies for psoriasis target its immune components and may predict potential treatments for other inflammatory human diseases.

Download full-text PDF

Source
http://m-learning.zju.edu.cn/G2S/eWebEditor/uploadfile/20140
Web Search
http://www.nature.com/doifinder/10.1038/nature05663
Publisher Site
http://dx.doi.org/10.1038/nature05663DOI Listing
February 2007
6 Reads

Publication Analysis

Top Keywords

therapies psoriasis
4
reversible appropriate
4
appropriate therapy
4
newest therapies
4
trigger keratinocyte
4
therapy trigger
4
fully reversible
4
psoriasis target
4
aberrant differentiation
4
immune components
4
immune-related cytokines
4
target immune
4
keratinocytes fully
4
keratinocyte response
4
pathogenesis newest
4
cells dendritic
4
system cells
4
dendritic cells
4
cytokines chemokines
4
cells immune-related
4

References

(Supplied by CrossRef)

JG Krueger et al.
J. Am. Acad. Dermatol. 2002

M Lebwohl et al.
Lancet 2003

BJ Nickoloff et al.
J. Clin. Invest. 2004

AM Bowcock et al.
Nature Rev. Immunol. 2005

MP Schon et al.
N. Engl. J. Med. 2005

AA Gaspari et al.
J. Am. Acad. Dermatol. 2006

A Davidson et al.
N. Engl. J. Med. 2001

Y Liu et al.
Genes & Immunity 2006

TE Christensen et al.
J. Invest. Dermatol. 2006

W Lew et al.
Br. J. Dermatol. 2004

RA Clark et al.
J. Immunol. 2006

Similar Publications